|
Fred Banti (B.S., M.S.)
President, Phosphagenics Inc.
Mr Banti joined Phosphagenics in 2008 as Senior Vice President and Chief Business Officer working out of its New York office.
He has more than 29 years experience as a pharmaceutical executive with strong management credentials in corporate, business and strategy development, portfolio and project management, commercial assessments and R&D. He possesses a thorough understanding of the drug development and commercialisation process.
From 2006 to 2008, he was VP Business Development for Gemin X Inc.; a private Venture backed Oncology Company. Prior to that, he was VP Life Sciences at Wood Mackenzie, VP Corporate Development for Penwest Pharmaceutical, VP Global Business Development for Novartis Oncology and Senior Director, Corporate Licensing and Global Head of Infectious Disease Licensing at Pharmacia (now Pfizer). These senior appointments followed 18 years in a variety of research and commercial positions within Rhone Poulenc Rorer (now Sanofi Aventis), culminating in his appointment from 1994-1999 as Director, Corporate Worldwide Business Development and Licensing.
Mr Banti graduated from Fairfield University (BS, Biology) in 1979 and the University of Pennsylvania (MS, Organizational Planning) in 1990. He is a non executive Director of Atlantic Healthcare Limited in the UK.
|